Citadel Advisors’s LAVA Therapeutics LVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.4K | Buy |
51,804
+46,781
| +931% | +$61.8K | ﹤0.01% | 5389 |
|
|
2025
Q1 | $6.38K | Buy |
+5,023
| New | +$6.38K | ﹤0.01% | 5722 |
|
|
2024
Q4 | – | Sell |
-17,013
| Closed | -$28.2K | – | 6449 |
|
|
2024
Q3 | $28.2K | Sell |
17,013
-49,224
| -74% | -$81.7K | ﹤0.01% | 5261 |
|
|
2024
Q2 | $119K | Buy |
+66,237
| New | +$119K | ﹤0.01% | 4882 |
|
|
2024
Q1 | – | Sell |
-21,552
| Closed | -$34.1K | – | 6557 |
|
|
2023
Q4 | $34.1K | Buy |
+21,552
| New | +$34.1K | ﹤0.01% | 5244 |
|
|
2023
Q2 | – | Sell |
-27,898
| Closed | -$46.3K | – | 6192 |
|
|
2023
Q1 | $46.3K | Buy |
+27,898
| New | +$46.3K | ﹤0.01% | 5187 |
|
|
2021
Q3 | – | Sell |
-61,874
| Closed | -$674K | – | 6805 |
|
|
2021
Q2 | $674K | Buy |
61,874
+1,432
| +2% | +$15.6K | ﹤0.01% | 4429 |
|
|
2021
Q1 | $918K | Buy |
+60,442
| New | +$918K | ﹤0.01% | 4012 |
|